|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$73,642
|
$73,642
|
Hickstein, Dennis
|
CCR (NCI)
|
|
|
Zbtb family members in lymphocyte differentiation and function
|
ZIA BC 011429
|
$341,950
|
$341,950
|
Kovalovsky, Damian
|
CCR (NCI)
|
|
|
Young Minority Scientists in the Field of Cancer
|
2R13CA040577-30
|
$69,443
|
$69,443
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
|
Young Investigator travel support for the 2016 through 2020 APS Annual Scientific
|
1R13AT009161-01
|
$5,000
|
$5,000
|
Price, Theodore
|
AMERICAN PAIN SOCIETY
|
|
|
Yale Cancer Biology Training Grant
|
1T32CA193200-01A1
|
$231,708
|
$231,708
|
GLAZER, PETER
|
YALE UNIVERSITY
|
|
|
Xenobiotic receptors
|
ZIA BC 005562
|
$719,839
|
$719,839
|
Gonzalez, Frank
|
CCR (NCI)
|
|
|
Workshop on Techniques in Modeling Human Cancer in Mice
|
5R25CA172010-03
|
$70,396
|
$70,396
|
MILLS, KEVIN
|
JACKSON LABORATORY
|
|
|
Women's Interagency HIV Study (WIHS-V)
|
5U01AI035004-24
|
$144,370
|
$144,370
|
ANASTOS, KATHRYN
|
"ALBERT EINSTEIN COLLEGE OF MEDICINE, IN
|
|
|
Wisconsin NCI Community Oncology Research Program (WiNCORP)
|
5UG1CA189956-03
|
$1,478,551
|
$1,478,551
|
ONITILO, ADEDAYO
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
|
|
Wisconsin and New Jersey Alliance in Precision Experimental Therapeutics
|
5UM1CA186716-03
|
$567,987
|
$567,987
|
KAUFMAN, HOWARD
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
|
WIHS Data Management and Analysis Center (WDMAC)
|
4U01AI042590-19
|
$95,311
|
$95,311
|
Gange, Stephen
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Why red-haired individuals are so prone to developing melanoma
|
5R01CA196896-02
|
$374,464
|
$374,464
|
CUI, RUTAO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
WEBSITE AND COMMUNICATION SERVICES FOR DCCPS. PERIOD OF PERFORMANCE 07/01/2016-06/30/2017.
|
261201200010I
|
$4,757,652
|
$4,757,652
|
UNKNOWN, UNKNOWN
|
ICF MACRO, INC.
|
|
|
WEB BASED EDUCATIONAL MODULE PROVIDING TRAINING ON THE 2017 SOLID TUMOR MULTIPLE PRIMARY AND HISTOLOGY CODING RULES
|
261201600780P
|
$22,030
|
$22,030
|
UNKNOWN, UNKNOWN
|
NATIONAL CANCER REGISTRAR'S ASSOCIATION
|
|
|
Weakened spindle checkpoint in vivo: a cause of aneuploidy and cancer in FA?
|
1F30CA200227-01A1
|
$27,801
|
$27,801
|
CERABONA, DONNA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
WDR5 as a Critical Co-Factor for MYC
|
1F31CA210429-01
|
$28,248
|
$28,248
|
FOSHAGE, AUDRA
|
VANDERBILT UNIVERSITY
|
|
|
Washington Women's Interagency HIV/AIDS Study
|
4U01AI034994-23
|
$106,140
|
$106,140
|
KASSAYE, SEBLE
|
GEORGETOWN UNIVERSITY
|
|
|
WASHINGTON UNIVERSITY PAUL CALABRESI CAREER DEVELOPMENT AWARD FOR CLINICAL ONCOLO
|
4K12CA167540-05
|
$1,043,545
|
$1,043,545
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
|
Washington University Cancer Genomics and Outcomes Research STRENGTH Program
|
5R25CA190190-02
|
$200,406
|
$200,406
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-02S1
|
$40,181
|
$40,181
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-02S2
|
$36,390
|
$36,390
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
|
Vitamin D and HA Signaling in TNBC
|
5R01CA194500-02
|
$352,275
|
$352,275
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
|
Visualization hub for genomics data exploration and translational discovery
|
1U24CA210974-01
|
$889,043
|
$889,043
|
ZHU, JINGCHUN
|
UNIVERSITY OF CALIFORNIA SANTA CRUZ
|
|
|
VISTA, a novel checkpoint that suppresses anti-tumor T cell responses
|
5R01CA164225-05
|
$15,589
|
$15,589
|
WANG, LI
|
MEDICAL COLLEGE OF WISCONSIN
|
|
|
Viral priming and targeting NK cells against solid tumor malignancies
|
5R35CA197292-02
|
$912,000
|
$912,000
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
|
|
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors
|
5R01CA178932-03
|
$402,550
|
$402,550
|
O'SHEA, CLODAGH
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
|
Viral oncoprotein targeted immune therapy for Merkel cell carcinoma
|
4R01CA176841-04
|
$637,515
|
$637,515
|
NGHIEM, PAUL
|
UNIVERSITY OF WASHINGTON
|
|
|
Viral Modulation of Genetic Stability
|
5R01CA097093-13
|
$399,000
|
$399,000
|
WEITZMAN, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
ViKTriY-PC Consortium Phase II Supplement
|
3UM1CA186689-03S1
|
$732,368
|
$732,368
|
LORUSSO, PATRICIA
|
YALE UNIVERSITY
|
|
|
ViKTriY Early Clinical Trials Consortium (ECTC)
|
3UM1CA186689-03S2
|
$167,500
|
$167,500
|
LORUSSO, PATRICIA
|
YALE UNIVERSITY
|
|
|
ViKTriY Early Clinical Trials Consortium (ECTC)
|
5UM1CA186689-03
|
$1,362,459
|
$1,362,459
|
LORUSSO, PATRICIA
|
YALE UNIVERSITY
|
|
|
Video Rate optical verification tool for radiotherapy treatment plans
|
2R44CA199681-02
|
$1,016,414
|
$1,016,414
|
WARE, WILLIAM
|
DOSEOPTICS, LLC
|
|
|
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis
|
5R01CA181648-03
|
$311,847
|
$311,847
|
LANG, JOSHUA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program
|
5UG1CA189869-03
|
$951,712
|
$951,712
|
GEYER, CHARLES
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Vault-CCL21 Nanocapsule for Lung Cancer
|
3U44CA167593-03S1
|
$168,750
|
$168,750
|
SRIVASTAVA, INDRESH
|
PROTEIN SCIENCES CORPORATION
|
|
|
Vascular Leukocytes Influence the Tumor Microenvironment
|
4R01CA124515-11
|
$350,170
|
$350,170
|
CONEJO-GARCIA, JOSE
|
WISTAR INSTITUTE
|
|
|
Validation of the Fes Tyrosine Kinase as an Inhibitor Target in Multiple Myeloma
|
5R21CA185702-02
|
$200,970
|
$200,970
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Validation of FOXM1 as a new therapeutic target in high-risk myeloma
|
1R21CA187388-01A1
|
$199,013
|
$199,013
|
JANZ, SIEGFRIED
|
UNIVERSITY OF IOWA
|
|
|
Validation of findings from the Epigenome-Wide Association Study of Breast Cancer
|
5U01CA184910-03
|
$181,456
|
$181,456
|
STURGEON, SUSAN
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
|
|
Validation of EGFR Protein Complexes as Molecular Diagnostics
|
1UH2CA202970-01
|
$390,763
|
$390,763
|
HAURA, ERIC
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer
|
2U01CA152662-06
|
$715,735
|
$715,735
|
MASSION, PIERRE
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Validation of a Room-Temperature Storage Technique for Plasma/Serum Biospecimens
|
1R33CA204510-01
|
$365,264
|
$365,264
|
AKSAN, ALPTEKIN
|
UNIVERSITY OF MINNESOTA
|
|
|
Validation of a rapid point-of-care breath test for breast cancer
|
1R44CA203019-01A1
|
$1,071,867
|
$1,071,867
|
PHILLIPS, MICHAEL
|
MENSSANA RESEARCH, INC.
|
|
|
Validation of 4-miRNA signature for early lung cancer detection
|
1R21CA205414-01
|
$218,987
|
$218,987
|
CHEN, GUOAN
|
UNIVERSITY OF MICHIGAN
|
|
|
Validation and humanization of a PET imaging agent that targets PD-L1.
|
1R43CA203138-01A1
|
$300,000
|
$300,000
|
GOSTISSA, MONICA
|
AGENUS, INC.
|
|
|
Validation and Clinical Relevance of Ovarian Cancer Molecular Subtypes
|
7R03CA191447-02
|
$81,250
|
$81,250
|
WALDRON, LEVI
|
GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH P
|
|
|
Validation and Advanced Development of Glycan Node Analysis in Lung Cancer Research
|
5R33CA191110-02
|
$240,355
|
$240,355
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Validation and Advanced Development of Duplex Sequencing
|
5R33CA181771-03
|
$377,887
|
$377,887
|
LOEB, LAWRENCE
|
UNIVERSITY OF WASHINGTON
|
|
|
Validating the protein binding domain of replication protein A as a cancer target
|
5R01CA174887-03
|
$325,775
|
$325,775
|
FESIK, STEPHEN
|
VANDERBILT UNIVERSITY
|
|
|
Validating the Patient-reported Experiences of Discrimination in Care Tool (PreDi
|
4R01CA169103-05
|
$644,476
|
$644,476
|
NUNEZ-SMITH, MARCELLA
|
YALE UNIVERSITY
|
|
Total relevant funding to Cancer for this search: $2,177,203,943
|
